(RTTNews) - Haemonetics Corp. (HAE) said Friday it supports new guidance issued by the U.S. Food and Drug Administration or FDA related to the use of viscoelastic testing for the duration of the ...

BOSTON, April 2, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, ...

In this context, there have been significant advancements in hemostasis testing device technology. Leading surgical practices are now harnessing the power of next-generation viscoelastic testing (VET) ...

HemoSonics’ Quantra System is FDA-cleared for use in cardiovascular and major orthopedic surgery, trauma, and liver transplantation. Quantra requires minimal ...

BOSTON, Jan. 22, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better ...

Healthcare & Pharmaceuticalscategory Measles cases in Texas rise to 505, state health department says April 8, 2025 Healthcare & Pharmaceuticalscategory South Sudan cholera patients died walking to ...

HemoSonics Wins 2025 Supplier Horizon Award from Premier, Inc. One of 13 companies to receive Premier, Inc.’s Supplier Horizon Award for excellence in improving healthcare performance, HemoSonics’ ...